TO DEVELOP AND CLINICALLY VALIDATE AN INNOVATIVE CELL-FREE DEOXYRIBONUCLEIC ACID (CFDNA) BASED PANEL FOR DETECTING DISEASE-CAUSING FUNGI DIRECTLY FROM PLASMA.

DEFINITIVE CONTRACT won by ZEPTO LIFE TECHNOLOGY, INC. · work in SAINT PAUL, MN
$1,878,981
RecipientZEPTO LIFE TECHNOLOGY, INC. UEI ELTELWNJZJ73
Award ID75N93026C00010
Award amount$1,878,981
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSCAN12
Start dateAug 3, 2026
End dateApr 30, 2027
Place of performanceSAINT PAUL, MN
Record updatedJul 17, 2026

View the official award record

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids